Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Carcinoma Stories

2011-10-25 09:39:13

Researchers confirmed an association between tanning bed use and an increased risk for three common skin cancers – basal cell carcinoma, squamous cell carcinoma and melanoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011. The popularity of indoor tanning is widespread, with roughly 10 percent of Americans using a tanning facility each year. However, use of tanning beds has been shown to be...

2011-09-01 12:48:20

The nature of the connective tissue surrounding lung cancer nests can help predict the aggressiveness of squamous cell carcinoma, according to research published in the September issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC). Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths worldwide; its two major subtypes are adenocarcinoma and squamous cell carcinoma (SqCC). Although...

2011-09-01 12:19:27

Study published in The American Journal of Pathology The first report of the presence of alternative lengthening of telomeres (ALT) in cancers arising from the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung was published today in The American Journal of Pathology. The presence of ALT in carcinomas can be used as a diagnostic marker and has implications for the development of anti-cancer drug therapies. Telomeres are nucleoprotein complexes located at the ends of...

2011-07-28 11:27:00

BOCA RATON, Fla., July 28, 2011 /PRNewswire/ -- Sensus Healthcare is pleased to announce that the Prince of Wales Hospital in Hong Kong has become the first healthcare facility in the country to purchase and deploy an SRT-100(TM) non-invasive skin cancer treatment system. The SRT-100(TM) will provide the local patient community with the most effective, non-surgical, and pain free therapy modality to treat non-Melanoma Basal and Squamous Cell skin cancers, which account for the vast majority...

2011-07-28 07:00:00

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Polaris Group (Polaris) today announced that it has dosed the first patient in a pivotal Phase 3 clinical trial evaluating its lead cancer therapeutic, pegylated arginine deiminase (ADI-PEG 20), in hepatocellular carcinoma (HCC) patients. Over 600 patients who have failed prior systemic therapy will be enrolled in the randomized, double-blind, placebo-controlled study at sites in China, Taiwan, the United States, Italy and the U.K.. Patients will...

2011-06-30 07:04:44

(Ivanhoe Newswire) "“ A key for early diagnosis of cancer and personalized medicine is the order of genetic aberrations - deviations or irregularity - in individual cancers. Now, scientists have begun to reveal the order of mutations that lead to cancer. "We know that each cancer is a collection of genetic malfunctions," Raymond Cho, Ph.D., assistant clinical professor in the department of dermatology at the University of California, San Francisco, was quoted as saying. "We now know it...

2011-06-30 01:37:16

Scientists have begun to reveal the order of the genetic aberrations in individual cancers in a finding they say is key to early diagnosis and personalized medicine. "We know that each cancer is a collection of genetic malfunctions," said Raymond Cho, Ph.D., an assistant clinical professor in the department of dermatology at the University of California, San Francisco (UCSF). "We now show it is possible to determine which changes happen earlier and which ones happen further down the road,...

2011-05-31 10:49:00

MARSEILLE, France, May 31, 2011 /PRNewswire-FirstCall/ -- IPSOGEN SA (Alternext: ALIPS) today announces that two studies on the Genomic Grade test will be presented at the American Society for Clinical Oncology (ASCO) Annual Meeting, that will take place June 3-7, 2011, in Chicago, Ill, USA. The Genomic Grade test (GG), a multi-gene expression test, improves tumor grading, long term prognostication, and consequently treatment decisions for women with early invasive hormone receptor...

2011-05-23 07:25:36

(Ivanhoe Newswire) -- Researchers say they have discovered a new drug target for squamous cell carcinoma -- the second most common form of skin cancer. Each year, more than 700,000 new cases of squamous cell carcinoma are diagnosed. This type of skin cancer develops in the cells that make up most of the skin's upper layers. Squamous cell carcinomas are most commonly found in areas exposed to the sun such as the rim of the ear, lower lip, face, scalp, neck, hands, arms and legs. Investigators...

2011-05-19 23:18:24

Researchers find that the protein alpha-catenin acts as a tumor suppressor and they reveal the mechanism by which it controls cell growth Researchers at Fred Hutchinson Cancer Research Center have discovered a new drug target for squamous cell carcinoma "“ the second most common form of skin cancer. Scientists in the laboratory of Valeri Vasioukhin, Ph.D., have found that a protein called alpha-catenin acts as a tumor suppressor and they also have unlocked the mechanism by which this...